Taysha Gene Therapies

TSHA

NASDAQHealth Care

Income Statement

Total Revenue$8.33M

Gross Profit$8.33M

Operating Income$-91.46M

EBITDA$-86.73M

EBIT$-89.2M

Pre-tax Income$-108.99M

Net Income$-89.3M

Cash Equivalent$150.96M

Total Debt$59.25M

Book Value$80.76M

Book Value Per Share0.41

Return on Equity (ROE)-124.85%

Return on Assets (ROA)-55.68%

Return on Invested Capital (ROI)-76.82%

Net Profit Margin-1071.62%

Current Ratio5.42

Quick Ratio5.34

Long-Term Debt / Equity0.61